CLS: Celestica Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Celestica Inc (CLS).

OverviewDividends

$10.74B Market Cap.

As of 07/29/2025 5:00 PM ET (MRY) • Disclaimer

CLS Market Cap. (MRY)


CLS Shares Outstanding (MRY)


CLS Assets (MRY)


Total Assets

$5.99B

Total Liabilities

$4.09B

Total Investments

$0

CLS Income (MRY)


Revenue

$9.65B

Net Income

$428.00M

Operating Expense

$449.40M

CLS Cash Flow (MRY)


CF Operations

$473.90M

CF Investing

-$212.50M

CF Financing

-$208.50M

CLS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$5,988,200,000 (1.66%)

$5,890,500,000 (4.66%)

$5,628,000,000 (20.59%)

$4,666,900,000 (27.37%)

Assets Current

$4,512,200,000 (0.04%)

$4,510,600,000 (4.24%)

$4,327,000,000 (25.96%)

$3,435,300,000 (25.50%)

Assets Non-Current

$1,476,000,000 (6.96%)

$1,379,900,000 (6.06%)

$1,301,000,000 (5.63%)

$1,231,600,000 (32.87%)

Goodwill & Intangible Assets

$648,500,000 (1.33%)

$640,000,000 (-4.23%)

$668,300,000 (-5.37%)

$706,200,000 (65.00%)

Shareholders Equity

$1,896,000,000 (7.06%)

$1,771,000,000 (5.56%)

$1,677,700,000 (14.68%)

$1,463,000,000 (3.83%)

Property Plant & Equipment Net

$661,600,000 (4.72%)

$631,800,000 (23.81%)

$510,300,000 (12.77%)

$452,500,000 (4.38%)

Cash & Equivalents

$423,300,000 (14.28%)

$370,400,000 (-1.09%)

$374,500,000 (-4.95%)

$394,000,000 (-15.05%)

Accumulated Other Comprehensive Income

$0 (0%)

-$200,000 (96.49%)

-$5,700,000 (78.73%)

-$26,800,000 (-76.32%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$1,760,600,000 (-16.33%)

$2,104,300,000 (-10.47%)

$2,350,300,000 (38.50%)

$1,697,000,000 (55.47%)

Trade & Non-Trade Receivables

$2,069,000,000 (15.22%)

$1,795,700,000 (28.86%)

$1,393,500,000 (10.57%)

$1,260,300,000 (15.26%)

Trade & Non-Trade Payables

$1,294,800,000 (-0.26%)

$1,298,200,000 (-9.90%)

$1,440,800,000 (16.35%)

$1,238,300,000 (44.92%)

Accumulated Retained Earnings (Deficit)

-$423,800,000 (50.25%)

-$851,800,000 (20.88%)

-$1,076,600,000 (14.26%)

-$1,255,600,000 (8.27%)

Tax Assets

$87,700,000 (27.29%)

$68,900,000 (-7.89%)

$74,800,000 (32.86%)

$56,300,000 (20.56%)

Tax Liabilities

$142,900,000 (34.18%)

$106,500,000 (-20.40%)

$133,800,000 (9.22%)

$122,500,000 (45.66%)

Total Debt

$796,700,000 (17.98%)

$675,300,000 (-14.09%)

$786,100,000 (-1.04%)

$794,400,000 (35.59%)

Debt Current

$26,500,000 (-1.85%)

$27,000,000 (-48.28%)

$52,200,000 (1.36%)

$51,500,000 (-48.40%)

Debt Non-Current

$770,200,000 (18.80%)

$648,300,000 (-11.66%)

$733,900,000 (-1.21%)

$742,900,000 (52.83%)

Total Liabilities

$4,092,200,000 (-0.66%)

$4,119,500,000 (4.28%)

$3,950,300,000 (23.30%)

$3,203,900,000 (42.07%)

Liabilities Current

$3,021,400,000 (-6.18%)

$3,220,500,000 (5.41%)

$3,055,200,000 (35.58%)

$2,253,500,000 (42.79%)

Liabilities Non-Current

$1,070,800,000 (19.11%)

$899,000,000 (0.44%)

$895,100,000 (-5.82%)

$950,400,000 (40.40%)

CLS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$9,646,000,000 (21.17%)

$7,961,000,000 (9.81%)

$7,250,000,000 (28.67%)

$5,634,700,000 (-1.97%)

Cost of Revenue

$8,612,300,000 (19.50%)

$7,206,900,000 (9.19%)

$6,600,300,000 (28.22%)

$5,147,700,000 (-3.07%)

Selling General & Administrative Expense

$293,500,000 (-3.20%)

$303,200,000 (13.43%)

$267,300,000 (9.06%)

$245,100,000 (6.24%)

Research & Development Expense

$78,000,000 (28.08%)

$60,900,000 (31.53%)

$46,300,000 (20.57%)

$38,400,000 (28.43%)

Operating Expenses

$449,400,000 (21.72%)

$369,200,000 (2.87%)

$358,900,000 (12.40%)

$319,300,000 (3.10%)

Interest Expense

$52,100,000 (-33.97%)

$78,900,000 (52.61%)

$51,700,000 (63.09%)

$31,700,000 (-15.92%)

Income Tax Expense

$104,200,000 (69.16%)

$61,600,000 (4.41%)

$59,000,000 (83.80%)

$32,100,000 (8.45%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$428,000,000 (75.12%)

$244,400,000 (35.70%)

$180,100,000 (73.34%)

$103,900,000 (71.45%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$428,000,000 (75.12%)

$244,400,000 (35.70%)

$180,100,000 (73.34%)

$103,900,000 (71.45%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$428,000,000 (75.12%)

$244,400,000 (35.70%)

$180,100,000 (73.34%)

$103,900,000 (71.45%)

Weighted Average Shares

$118,100,000 (-1.67%)

$120,100,000 (-2.75%)

$123,500,000 (-2.53%)

$126,700,000 (-1.86%)

Weighted Average Shares Diluted

$118,700,000 (-1.33%)

$120,300,000 (-2.67%)

$123,600,000 (-2.45%)

$126,700,000 (-1.86%)

Earning Before Interest & Taxes (EBIT)

$584,300,000 (51.81%)

$384,900,000 (32.36%)

$290,800,000 (73.40%)

$167,700,000 (31.12%)

Gross Profit

$1,033,700,000 (37.08%)

$754,100,000 (16.07%)

$649,700,000 (33.41%)

$487,000,000 (11.29%)

Operating Income

$584,300,000 (51.81%)

$384,900,000 (32.36%)

$290,800,000 (73.40%)

$167,700,000 (31.12%)

CLS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$212,500,000 (-73.61%)

-$122,400,000 (-12.40%)

-$108,900,000 (70.11%)

-$364,300,000 (-614.31%)

Net Cash Flow from Financing

-$208,500,000 (-0.29%)

-$207,900,000 (-70.83%)

-$121,700,000 (-279.76%)

$67,700,000 (133.14%)

Net Cash Flow from Operations

$473,900,000 (45.28%)

$326,200,000 (54.52%)

$211,100,000 (-6.92%)

$226,800,000 (-5.34%)

Net Cash Flow / Change in Cash & Cash Equivalents

$52,900,000 (1390.24%)

-$4,100,000 (78.97%)

-$19,500,000 (72.06%)

-$69,800,000 (-344.59%)

Net Cash Flow - Business Acquisitions and Disposals

-$36,100,000 (0%)

$0 (0%)

$0 (0%)

-$314,700,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$168,000,000 (-37.25%)

-$122,400,000 (-12.40%)

-$108,900,000 (-119.56%)

-$49,600,000 (2.75%)

Issuance (Repayment) of Debt Securities

$111,500,000 (489.86%)

-$28,600,000 (32.55%)

-$42,400,000 (-128.27%)

$150,000,000 (196.40%)

Issuance (Purchase) of Equity Shares

-$232,700,000 (-128.14%)

-$102,000,000 (-196.51%)

-$34,400,000 (3.64%)

-$35,700,000 (-35600.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$57,400,000 (3.24%)

$55,600,000 (9.02%)

$51,000,000 (52.69%)

$33,400,000 (29.46%)

Depreciation Amortization & Accretion

$151,900,000 (16.13%)

$130,800,000 (12.86%)

$115,900,000 (-8.23%)

$126,300,000 (1.28%)

CLS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

10.70% (12.63%)

9.50% (5.56%)

9.00% (4.65%)

8.60% (13.16%)

Profit Margin

4.40% (41.94%)

3.10% (24.00%)

2.50% (38.89%)

1.80% (63.64%)

EBITDA Margin

7.60% (16.92%)

6.50% (16.07%)

5.60% (7.69%)

5.20% (18.18%)

Return on Average Equity (ROAE)

23.70% (65.73%)

14.30% (24.35%)

11.50% (59.72%)

7.20% (63.64%)

Return on Average Assets (ROAA)

7.30% (69.77%)

4.30% (26.47%)

3.40% (30.77%)

2.60% (62.50%)

Return on Sales (ROS)

6.10% (27.08%)

4.80% (20.00%)

4.00% (33.33%)

3.00% (36.36%)

Return on Invested Capital (ROIC)

21.80% (33.74%)

16.30% (25.38%)

13.00% (44.44%)

9.00% (25.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

25.5 (76.77%)

14.42 (86.86%)

7.72 (-43.13%)

13.57 (-20.95%)

Price to Sales Ratio (P/S)

1.13 (155.66%)

0.44 (130.21%)

0.19 (-23.20%)

0.25 (38.12%)

Price to Book Ratio (P/B)

5.67 (187.37%)

1.97 (138.45%)

0.83 (-15.78%)

0.98 (33.06%)

Debt to Equity Ratio (D/E)

2.16 (-7.22%)

2.33 (-1.23%)

2.35 (7.53%)

2.19 (36.87%)

Earnings Per Share (EPS)

3.62 (78.33%)

2.03 (39.04%)

1.46 (78.05%)

0.82 (74.47%)

Sales Per Share (SPS)

81.68 (23.22%)

66.29 (12.92%)

58.7 (32.00%)

44.47 (-0.11%)

Free Cash Flow Per Share (FCFPS)

2.59 (52.62%)

1.7 (104.95%)

0.83 (-40.81%)

1.4 (-4.24%)

Book Value Per Share (BVPS)

16.05 (8.87%)

14.75 (8.55%)

13.59 (17.65%)

11.55 (5.80%)

Tangible Assets Book Value Per Share (TABVPS)

45.21 (3.42%)

43.72 (8.86%)

40.16 (28.47%)

31.26 (24.71%)

Enterprise Value Over EBIT (EV/EBIT)

19 (90.00%)

10 (66.67%)

6 (-33.33%)

9 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

15.33 (101.17%)

7.62 (70.61%)

4.47 (-14.21%)

5.21 (12.68%)

Asset Turnover

1.64 (16.47%)

1.41 (1.88%)

1.38 (-1.85%)

1.41 (-9.45%)

Current Ratio

1.49 (6.57%)

1.4 (-1.06%)

1.42 (-7.09%)

1.52 (-12.11%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$305,900,000 (50.10%)

$203,800,000 (99.41%)

$102,200,000 (-42.33%)

$177,200,000 (-6.04%)

Enterprise Value (EV)

$11,286,320,000 (187.16%)

$3,930,304,000 (116.36%)

$1,816,537,000 (18.66%)

$1,530,936,695 (31.16%)

Earnings Before Tax (EBT)

$532,200,000 (73.92%)

$306,000,000 (27.98%)

$239,100,000 (75.81%)

$136,000,000 (50.78%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$736,200,000 (42.76%)

$515,700,000 (26.80%)

$406,700,000 (38.33%)

$294,000,000 (16.39%)

Invested Capital

$2,691,700,000 (15.28%)

$2,334,900,000 (0.81%)

$2,316,100,000 (9.89%)

$2,107,600,000 (18.40%)

Working Capital

$1,490,800,000 (15.56%)

$1,290,100,000 (1.44%)

$1,271,800,000 (7.62%)

$1,181,800,000 (1.97%)

Tangible Asset Value

$5,339,700,000 (1.70%)

$5,250,500,000 (5.86%)

$4,959,700,000 (25.22%)

$3,960,700,000 (22.39%)

Market Capitalization

$10,743,720,000 (207.57%)

$3,493,104,000 (151.78%)

$1,387,337,000 (-3.41%)

$1,436,336,695 (38.19%)

Average Equity

$1,807,650,000 (5.66%)

$1,710,850,000 (8.86%)

$1,571,600,000 (8.93%)

$1,442,800,000 (4.73%)

Average Assets

$5,878,625,000 (4.03%)

$5,651,100,000 (7.82%)

$5,241,100,000 (31.09%)

$3,997,950,000 (8.20%)

Invested Capital Average

$2,686,325,000 (13.57%)

$2,365,425,000 (5.59%)

$2,240,100,000 (20.13%)

$1,864,725,000 (5.68%)

Shares

116,400,000 (-2.43%)

119,300,000 (-3.09%)

123,100,000 (-4.61%)

129,050,916 (0.20%)